Ticker Symbol: CPIX
Cumberland Pharmaceuticals Inc.
$2.60 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001087294
Company Profile
Cumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and products conceived at Vanderbilt and other regional research centers to the marketplace. CET helps manage the development and commercialization process for select projects and provides expertise on intellectual property, regulatory, manufacturing and marketing issues that are critical to successful new biomedical products. CET's Life Sciences Center, located in Nashville, Tennessee, provides laboratory space, equipment and infrastructure to early-stage life sciences companies.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.cumberlandpharma.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.79
Change:
$0.01
(
0.56%)
Days Range: $1.63 - $1.87
Beta: 0.06
52wk. High: $2.91
52wk. Low: $1.43
Ytd. Change -20.33%
50 Day Moving Average: $1.93
200 Day Moving Average: $1.73
Shares Outstanding: 14371214
Valuation
Market Cap: 2.6B
PE Ratio: -15.84
EPS (TTM): -0.113
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A